Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to -$28.4 million.

  • AVITA Medical's Cost of Revenue rose 1882.14% to -$28.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.8 million, marking a year-over-year increase of 4069.72%. This contributed to the annual value of $12.8 million for FY2025, which is 4068.62% up from last year.
  • AVITA Medical's Cost of Revenue amounted to -$28.4 million in Q4 2025, which was up 1882.14% from $12.1 million recorded in Q3 2025.
  • Over the past 5 years, AVITA Medical's Cost of Revenue peaked at $16.3 million during Q2 2024, and registered a low of -$35.0 million during Q4 2024.
  • In the last 5 years, AVITA Medical's Cost of Revenue had a median value of $6.5 million in 2023 and averaged $4.9 million.
  • Per our database at Business Quant, AVITA Medical's Cost of Revenue soared by 9464.05% in 2023 and then tumbled by 44252.15% in 2024.
  • Over the past 5 years, AVITA Medical's Cost of Revenue (Quarter) stood at $3.5 million in 2021, then soared by 80.27% to $6.3 million in 2022, then skyrocketed by 61.08% to $10.2 million in 2023, then tumbled by 442.52% to -$35.0 million in 2024, then grew by 18.82% to -$28.4 million in 2025.
  • Its Cost of Revenue was -$28.4 million in Q4 2025, compared to $12.1 million in Q3 2025 and $14.3 million in Q2 2025.